Iannazzo, Sergio, Edoardo Mannucci, and Lorenzo Mantovani. “[Budget Impact Analysis of Empagliflozin for the Treatment of Type 2 Diabetes in Italy]”. Farmeconomia. Health economics and therapeutic pathways 17, no. 1 (March 31, 2016): 19–27. Accessed July 23, 2025. https://provafe.seedstm.com/index.php/FE/article/view/1238.